ESMED Statement of Support for Ukraine
The unprovoked invasion of Ukraine continues to escalate, with the number of casualties and civilians displaced from their homes reaching the thousands. This humanitarian crisis cannot be condoned. The European Society of Medicine and the international community stand united in solidarity with the people of Ukraine and with the Russian citizens protesting against the invasion. Over the past four weeks, we have witnessed the appalling atrocities the Ukrainian community faces. However, in this time of crisis, there has also been worldwide condemnation of President Putin’s invasion of Ukraine and an outpouring of support for those caught up in this conflict. ESMED sends their support for all appropriate action to be taken to end this conflict and guarantee the safety of the Ukrainian people. Collaboration has been the cornerstone of many great scientific and medical discoveries, and we must safeguard academic freedom and the autonomy of science and research. It is our hope that this war ends quickly with the recognition of Ukraine as a free and independent nation.
– Dr. Alison McNeilly, on behalf of the ESMED board
Feedback from ESMED Congress 2021
The ESMED General Assembly (2022) allowed me to present my work on new optimization methods in drug discovery at the preclinical level to a much wider audience of patient-related doctors and clinicians; not many conferences are able to bridge this gap.
Celerino Abad-Zapatero, Ph.D.
University of Illinois at Chicago
I wish to thank you for the opportunity you gave to me to present in your congress in Vienna in 2021 our new approach of the melanoma problem. Also the active participation of the audience was not just a common one. In between I hope that until your next congress this year we will have more new results to present.
To have an idea is the first step, but to arrive even to results is the ultimate step.
University of Patras
Related to the past ESMED 2021 congress in Viena my experience was good. Both, the Organization and Congress were of high quality. However, in my case, the problem was that only few attendants were during my talk, maybe as a consequence of having two rooms functioning at the same time that could be merged.
Diego Caicedo Valdés, MD, PhD.
Universitario de Santiago de Compostela
Medical Research Archives
More than 2,000 original articles, reviews, and case reports
Special Journal Issues
Latest Journal Articles
John Pacella et. al.
University of Pittsburgh
The coronavirus disease of 2019 (COVID-19) is a global medical crisis that has posed immense challenges to the medical fraternity worldwide. COVID-19 is caused by Severe Acute Respiratory Syndrome – Corona Virus – 2 (SARS-CoV-2) that targets
Scott Wright et al.
Johns Hopkins University
Because limited research has been performed to characterize clinical excellence in graduate medical education, we used qualitative methods to characterize elements most pertinent to
Annekathryn Goodman et. al. Harvard University
Human Papillomavirus (HPV) vaccination should be included in national immunization programs, as part of a comprehensive approach to cervical cancer prevention and control. The practical aspects
Asif K Mustafa et al.
Hydrogen Sulfide, a pungent gas traditionally thought to be toxic to the human body, is now emerging as one of the most important endogenously synthesized gaseous transmitters. Over the course of the past decade
Journal Citation Report
GeoVax Presents COVID-19 Vaccine Data at the European Society of Medicine General Assembly
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today presented data from ongoing studies of its preventive vaccine against COVID-19. The presentation titled, “Design of a Universal SARS-CoV-2 Vaccine Against Evolving Variants,” was delivered virtually by Mark J. Newman, Ph.D., GeoVax’s Chief Scientific Officer, during the European Society of Medicine (ESMED) General Assembly, being held August 19-21 in Berlin, Germany.
Call for a new globally equitable vaccine strategy
An open letter to the World Health Organization
Addressing the highly unequal distribution of vaccines is critically important to putting an end to the COVID-19 pandemic. The vaccine-sharing initiative COVAX was supposed to serve as a lifeline for many countries in the developing world but is failing to deliver even 25% of the doses expected. The time has come to take action to ensure a sustainable vaccine supply across the globe.
Show your support by signing the letter.
Become an ESMED member and gain access to member-only webinars, videos, networking events and more.